European Pharmaceutical Review

DECEMBER 14, 2023

Decisions to remove medicines from market are not taken lightly and are often based upon all evidence available to inform a benefit/risk balance. Article (Samantha Lane): How can evidence-based medicine (EBM) methodology support drug withdrawals? Internet] European Medicines Agency. Internet] European Medicines Agency.

Safety 111

Safety Medicine Competition Networking 111

Pharmaceutical Technology

FEBRUARY 24, 2023

The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation. She also cautioned against believing that all of the problems with Europe’s medicines can be solved with regulation. What’s in the draft?

Pharma 64

Pharma Medicine Competition Food 64

World of DTC Marketing

DECEMBER 30, 2020

Institute of Medicine of the National Academies. By 2001, the amount rose to 11%. (BMJ Research). This leads to obesity. It is estimated that $190.2 billion of the United States annual healthcare expenditure is related to obesity-related illnesses. Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation”).

Government 181

Government Food Healthcare Healthcare 181

pharmaphorum

OCTOBER 6, 2022

Most often, this has involved artificial recreation of natural molecules with medicinal properties; however, such a process is both time consuming and extremely costly. This is Barry Sharpless’ second Nobel Prize in Chemistry – the first was in 2001 for chiral catalysts. pic.twitter.com/5tu6aOedy4.

Pharmaceutical research 52

Pharmaceutical research Pharmaceutical Medicine 52

European Pharmaceutical Review

JUNE 8, 2023

9″ It will be interesting to see whether FDA tries to control carcinogenic TSNAs in tobacco products using an acceptable intake (AI) strategy, aligned with approaches applied to medicinal products for nitrosamines. The AIs for NNN and NNK are 96.0 μg/g tobacco (ie, 306-7400 ng/g tobacco) and NNK: 0.194-3.2 Internet] OJEU. Internet] FDA.

Food and Drug Administration 59

Food and Drug Administration FDA Manufacturing Law & Regulation 59

Pharmaceutical Technology

FEBRUARY 28, 2023

In the years between 2001-2010, a total of 1,527 designations were granted – almost triple the amount seen across the previous 17 years. The next generation of orphan drug launches Looking at some of the more recent orphan drug approvals, it is clear that advancements in genomic medicine are now shaping the next generation.

Medicine 52

Medicine Distribution Marketing Pharmaceutical 52

European Pharmaceutical Review

SEPTEMBER 14, 2023

While the pharmaceutical industry has long been considered recession-proof—with a constant demand for medicines and new treatment options, today, the industry is facing several major challenges. In 2001 and 2007, through 2009, the economy was hit hard. 1 We can only learn from the past and try not to repeat history.

Manufacturing 81

Manufacturing Engineering Management Pharmaceutical 81

pharmaphorum

SEPTEMBER 13, 2022

Although early accounts of an illness akin to leukaemia can be traced back to Ancient Greece, the first official description of blood cancer didn’t appear until 1832, when British pathologist and pioneer of preventative medicine Thomas Hodgkin used the controversial concept of micrology to identify the abnormalities in the lymphatic system.

Food and Drug Administration 82

Food and Drug Administration Patients Engineering Physicians 82

Pharmaceutical Technology

MAY 3, 2023

These medicines comprise about 10% of all generics approved each year. According to the FDA, the introduction of generic medicines offers patients “same as brand” drugs at 39% lower-than-average price,” says Surbhi Gupta, an industry analyst within Frost & Sullivan’s healthcare and life sciences practice area.

Food and Drug Administration 98

Food and Drug Administration FDA Medicine Competition 98

Pharmaceutical Technology

JUNE 29, 2022

During 2001–10, the number of granted designations almost tripled, with 1,527 drugs receiving their first orphan drug designation. Based on Pharmaceutical Technology’s analysis, between 1983 and 2000, only 568 drugs received their first orphan drug designation for a specific therapeutic indication.

Food and Drug Administration 98

Food and Drug Administration FDA Marketing Pharmaceutical 98

Pharmaceutical Technology

FEBRUARY 20, 2023

He says these issues must be urgently addressed over the next few years as advancing medical knowledge and the role of genomics in treating disease ushers in a new era of precision medicine and new potential to address diseases that affect certain populations. Hans Bunschoten: Viroclinics was founded in 2001, spun out of a university setting.

Healthcare 52

Healthcare Healthcare Medicine Biopharma 52

European Pharmaceutical Review

JULY 20, 2023

Impact on ATMPs The revision of the BTC legislation is especially important for life science companies developing advanced therapy medicinal products (ATMPs, such as cell and gene therapies), as requirements for donation, procurement and testing apply to SoHOs used in the production of ATMPs.

Safety 63

Safety Distribution Food Medical 63

PM360

OCTOBER 5, 2023

Later in his career he transitioned to the agency side and launched Weisscom Partners in 2001, which ultimately evolved into Real Chemistry. Advancing Breast Cancer Health Equity at the Point of Care” (Susan G.

Education 52

Education Marketing Media Biopharma 52

Pharmaceutical Technology

JULY 10, 2008

As the blockbuster drugs of the 90s that earned the industry billions reach their patent shelf lives, pharmaceutical companies require new medicines to sustain an estimated $157bn worth of sales. Those 38 products generated just $10bn of the $316bn industry’s entire portfolio of medicines.

Food and Drug Administration 52

Food and Drug Administration Medicine Pharmaceutical Government 52

PM360

AUGUST 24, 2023

Later in his career he transitioned to the agency side and launched Weisscom Partners in 2001, which ultimately evolved to Real Chemistry. and Scientific Global Communications) Consultation Tool for Aesthetic Practitioners (Allergan Aesthetics, an AbbVie company and MedTrix Healthcare) Discover TD Solution (Neurocrine Biosciences, Inc.

Marketing 52

Marketing Education Media Healthcare 52

Evolve Your Success

JUNE 21, 2022

For context, Cyber Tuesday, which is the Tuesday after Thanksgiving was developed in 2001. I spent a month in a hotel in Chicago learning about cardiovascular medicine. I was like, “I am busting my hump and I love my medicines.”. He’s like, “We’ll start small and we’ll keep improving the customer experience. I got all my pens.

Sales 52

Sales Pharma Pharmaceutical Sales Medical 52

Pharmaceutical Technology

OCTOBER 5, 2008

“In 2001, Japan’s Taisho Pharmaceutical tried to merge with Tanabe, but it failed due to differences in corporate culture.’ “Japanese companies did very few M&As, they were too independent to do more,” says Kaoru K Sato, managing director at PricewaterhouseCoopers (PwC).

Government 52

Government Marketing Pharmaceutical Physicians 52

Cadensee

JULY 5, 2021

I said that I probably can contribute even without having seven years of medical background or studying medicines, to contribute to this world and to help make it a little bit better. it started somewhere there in 2001, something like that, where pain become like the fifth vital sign.

Physicians 52

Physicians Medical Patients Management 52